Literature DB >> 34590259

The Use of Experimental Evolution to Study the Response of Pseudomonas aeruginosa to Single or Double Antibiotic Treatment.

Isabella Santi1, Pablo Manfredi1, Urs Jenal2.   

Abstract

The widespread use of antibiotics promotes the evolution and dissemination of drug resistance and tolerance. Both mechanisms promote survival during antibiotic exposure and their role and development can be studied in vitro with different assays to document the gradual adaptation through the selective enrichment of resistant or tolerant mutant variants. Here, we describe the use of experimental evolution in combination with time-resolved genome analysis as a powerful tool to study the interaction of antibiotic tolerance and resistance in the human pathogen Pseudomonas aeruginosa . This method guides the identification of components involved in alleviating antibiotic stress and helps to unravel specific molecular pathways leading to drug tolerance or resistance. We discuss the influence of single or double drug treatment regimens and environmental aspects on the evolution of antibiotic resilience mechanisms.
© 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adaptation; Aminoglycosides; Antibiotic tolerance; Cyclical treatment; Experimental evolution; Fluoroquinolones; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2021        PMID: 34590259     DOI: 10.1007/978-1-0716-1621-5_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Evolution of Antibiotic Tolerance Shapes Resistance Development in Chronic Pseudomonas aeruginosa Infections.

Authors:  Isabella Santi; Pablo Manfredi; Enea Maffei; Adrian Egli; Urs Jenal
Journal:  mBio       Date:  2021-02-09       Impact factor: 7.867

  1 in total
  1 in total

1.  Cell Envelope Stress Response in Pseudomonas aeruginosa.

Authors:  Sylvie Chevalier; Emeline Bouffartigues; Damien Tortuel; Audrey David; Ali Tahrioui; Clarisse Labbé; Magalie Barreau; Anne-Sophie Tareau; Mélissande Louis; Olivier Lesouhaitier; Pierre Cornelis
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.